Article

Bbarrons.com on 2021-07-16 14:31

Another Setback for Biogen’s Controversial Alzheimer’s Drug1 min read

Two major hospitals said they won’t administer Biogen’s drug to treat Alzheimer’s disease.

New York

Janet Woodcock

Related news

Biogen’s controversial Alzheimer’s drug made $1.6M in revenue in June New York Post
Rhode Island , Wall Street
BBiogen’s Alzheimer’s Drug Has Another Shot at Success3 min read barrons.com
Wall Street
FDA approves Biogen’s controversial Alzheimer’s drug New York Post
Phoenix , Massachusetts , Cambridge
FBiogen’s Alzheimer’s drug shows early promise ft.com
France , Nice , New York
What’s Behind Biogen’s Move To Cut Prices On Its Controversial Alzheimer’s Drug Aduhelm?Forbes
Florida , Phase 4
MBiogen’s controversial Alzheimer’s drug generates $2 million gross sales in first few weeks after approval mvtelegraph.com
Wall Street
Biogen Sees Heavy Patient Interest in New Alzheimer’s Drug4 min read wsj.com
Patti Davis Has Wisdom to Share With Alzheimer’s Caregivers7 min read wsj.com
New York , Los Angeles
BBiogen’s Alzheimer Drug Sales Were Dismal. Earnings Are Lifting the Stock.3 min read barrons.com
IHere’s why three hospitals are refusing to treat patients with Biogen’s new Alzheimer’s drug invezz.com
Providence , United States
Report Biogen’s Alzheimer’s drug shows early promise Reuters
NHow life stressors may increase Alzheimer’s risk7 min read nextavenue.org
Minneapolis , Montreal , Dallas , New York
BBiogen Announces New Trial for Alzheimer’s drug Aduhelm2 min read barrons.com
U.S. approves Eisai and Biogen’s drug to slow Alzheimer’s disease The Japan Times
Utah , Americas , New York , Cambridge , United States
BBiogen’s Alzheimer’s Drug Won’t Get Approved, Analyst Says barrons.com
Machina
BSigns Point to FDA Approval for Biogen’s Alzheimer’s Drug barrons.com
Phase 1 , Wall Street
Biogen’s $56 000 Alzheimer’s drug evades Biden’s cost curbs pressherald.com
Vermont